Improvement of quality of life in patients with concomitant allergic asthma and atopic dermatitis: one year follow-up of omalizumab therapy

OBJECTIVE: Anti IgE treatment with omalizumab is efficacious in the treatment of patients suffering from allergic asthma, improving asthma control and improving quality of life. Furthermore, this approach could be beneficial for patients with concomitant atopic dermatitis. We assessed quality of lif...

Descripción completa

Detalles Bibliográficos
Autores principales: Velling, P, Skowasch, D, Pabst, S, Jansen, E, Tuleta, I, Grohé, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352146/
https://www.ncbi.nlm.nih.gov/pubmed/22024441
http://dx.doi.org/10.1186/2047-783X-16-9-407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352146/
https://www.ncbi.nlm.nih.gov/pubmed/22024441
http://dx.doi.org/10.1186/2047-783X-16-9-407

Ejemplares similares